Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soar
Europe’s biggest firm, whose sales of Wegovy almost doubled, feels it can ‘meet demands’ of US administrationEurope’s biggest company, Novo Nordisk, has rebuffed fears of a hit to its business from Donald Trump’s threatened tariffs as sales of its weight-loss drug Wegovy almost doubled.Since the US president took office, he has imposed tariffs on Mexico and Canada – since paused for a month – and China, and has said levies of imports from the EU will “definitely happen”. Continue reading...
Europe’s biggest firm, whose sales of Wegovy almost doubled, feels it can ‘meet demands’ of US administration
Europe’s biggest company, Novo Nordisk, has rebuffed fears of a hit to its business from Donald Trump’s threatened tariffs as sales of its weight-loss drug Wegovy almost doubled.
Since the US president took office, he has imposed tariffs on Mexico and Canada – since paused for a month – and China, and has said levies of imports from the EU will “definitely happen”. Continue reading...
